ArticleThe pharmacogenomics journal2015

Genetic polymorphisms in the mevalonate pathway affect the therapeutic response to alendronate treatment in postmenopausal Chinese women with low bone mineral density.

C Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.